Date Posted
This webinar will focus on HPV-related head and neck cancer (HNC). The incidence of HNC, including oropharyngeal cancer (OPC), is on the rise in many countries, with a significant number of OPC cases caused by human papillomavirus (HPV) infections. Current prophylactic HPV vaccines can eventually prevent HPV-related cancers, as has already been shown for cervical cancer in young women. However, several generations of people remain at risk of HPV-associated OPC for whom prophylactic HPV vaccination may not be offered and would have limited or no benefit. Early detection could optimize effective intervention and treatment to reduce deaths caused by HPV-related OPCs.
Point of Contact
Wendy Wang, Ph.D., M.Sc.
Program Officer
Cancer Biomarkers Research Group
NCI Division of Cancer Prevention
Contact Email: wangw@mail.nih.gov